Introduction
Members of the genus Lactobacillus were long thought to be among the most abundant microorganisms in the human gastrointestinal (GI) tract and associated with good intestinal health. Following the development of culture-independent, DNA-sequence analysis methods, the numbers of autochthonous Lactobacillus were adjusted to 1% of the total bacterial population in the distal human gut. One consequence of this change is that the relevance of this genus to human health has come under scrutiny. In contrast, there is increased acceptance of the application of allochthonous probiotic Lactobacillus in fermented foods and supplements as probiotics to maintain health and prevent and treat disease [1, 2] . Although human studies frequently show a benefit with probiotic administration [3] , the importance of intestinal Lactobacillus remains under question.
Human disease is increasingly correlated with fecal microbiota composition. Similarly, intestinal bacteria are frequently correlated with numerous other host (genetics, age) and environmental (diet, medication) factors. Such associations have been useful for identifying pathobionts associated with disease as well as taxa such as Faecalibacterium prausnitzii and Akkermansia muciniphila as beneficial members of the indigenous microbiota. Similarly, a number of recent publications in which cultureindependent methods were employed (e.g. 16S rRNA gene amplicon sequencing) identified Lactobacillus as being significantly enriched in the distal gut during either health or disease ( Figure 1 and Table 1 ). Because these approaches are largely untargeted, the outcomes provide an unbiased perspective on the relative importance of this genus weighed against other bacterial inhabitants of the GI tract. This review will address findings on the diversity and abundance of intestinal Lactobacillus resulting from gut microbiome studies and emerging mechanistic evidence of endogenous and ingested (probiotic) Lactobacillus species in the GI tract.
Abundance and diversity of intestinal Lactobacillus
Lactobacillus species have been isolated from the entirety of the human GI tract (oral cavity to feces) as well as the skin and vagina [4, 5] . This genus is estimated to constitute 6% of the total bacterial cell numbers in the human duodenum [6] and approximately 0.3% of all bacteria in the colon [4] ( Figure 2 ). These levels are similar to the numbers of lactobacilli found in pigs, ranging from 5% to 0.1% of total bacteria in the proximal [7] and distal [8] gut, respectively. Lactobacillus was found in higher quantities in rhesus macaques (up to 30% and 10% of all bacteria in the small and large intestine, respectively) [9]. Proportions of Lactobacillus in rodent models ranged between 30% and 60% of bacterial numbers in the ileum and approximately 25% in the colon [10,11] ( Figure 2 ). Lactobacillus can also dominate the human vaginal microbiota (90 to 100% of total bacteria present) and is found on the skin, but in much lower relative abundance [5] (Figure 2 ).
Only a few out of the >200 known Lactobacillus species have been consistently and repeatedly associated with the human GI tract. Recently, this number was increased to over 50 Lactobacillus species that were repeatedly detected in the stools of healthy volunteers [12 ] . The most abundant lactobacilli included L. casei, L. delbruckeii, L. murinus, L. plantarum, L. rhamnosus, and L. ruminus. Some of these species (e.g. L. rhamnosus and L. murinus) are rarely isolated from environments outside the intestine and are considered gut-autochthonous microorganisms. Other mucosal sites are colonized by distinct species (e.g. L. crispatus in the vagina) [13 ] . There also appears to be host-specificity among some Lactobacillus species, as shown for linages of L. reuteri [14] .
Infectious disease
Both human immunodeficiency virus (HIV)-infected humans and simian immunodeficiency virus (SIV)infected rhesus macaques harbor reduced numbers of intestinal Lactobacillus [15,16] ( Table 1) . Lactobacillus depletion in rhesus macaques was associated with the loss of gut barrier-promoting T-helper 17 (Th17) cells and increased microbial translocation [16] . The potential of Lactobacillus to prevent or reverse intestinal damage during infection was demonstrated with the reduced interleukin-1b-mediated inflammation and improved barrier function upon inoculation of L. plantarum directly into ileal loops of SIV+ macaques shortly after SIV infection [17] . The intestinal epithelium in healthy animals responded similarly to L. plantarum, consistent with the finding that the ileal transcriptomes of L. plantarum were indistinguishable between SIV+ and SIVÀ animals [18] . In human populations, HIV+ patients on a multi-strain probiotic supplement containing strains of Lactobacillus and other genera contained higher numbers of memory Th17 cells in peripheral blood and in the intestine, and histological examination of colonic biopsies indicated increased intestinal barrier function [19] .
Several recent animal studies have indicated a broader role for Lactobacillus in prevention and resolution of infectious disease. Tryptophan metabolites (indole aldehydes) produced by indigenous L. reuteri strains activate host aryl hydrocarbon receptors (AHR) to promote gut and vaginal epithelial barrier and antimicrobial responses required for limiting the expansion of Candida albicans, an opportunistic pathogen [20 ] . Autochthonous Lactobacillus might also have a role in the resolution of infectious disease and recovery of immune homeostasis. Although Yerstina enterocolitica infection was cleared from toll-like receptor 1 (TLR1) knockout mice, the intestine was activated toward an inflammatory phenotype and the gut microbiota was enriched with Desulfovibrionaceae while containing lower numbers of Lactobacillus [21 ]. Oral gavage with L. reuteri reduced anti-commensal antibodies, innate cytokines, and Th17 responses; thereby ameliorating immune hyper-reactivity [21 ] . Conversely, post-Yersinia pseudotuberculosis infection lactobacilli were cultured from enlarged gut-associated lymphoid tissue and were associated with chronic lymphadenopathy, indicating that these bacteria might contribute to chronic, immune hyper-reactivity [22] .
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)
A meta-analysis of reports investigating the fecal microbiomes from IBS patients and healthy subjects concluded 
Rheumatoid arthritis (RA)
The intestinal microbiota of patients with severe and early onset RA were shown to have increased proportions of L. salivarius, L. ruminus, and L. iners when compared to healthy, age-matched individuals [30 ] ( Table 1) . Enrichment of Lactobacillus spp. was also observed in collageninduced, arthritic mice [31] . These results are in opposition to recent RCTs of probiotics in RA patients. In one study, patients consuming L. casei had reduced disease activity scores, higher quantities of serum IL-10, and decreased levels of serum TNFa, IL-6 and IL-12 [32] . The other RCT concluded that a mixed strain probiotic supplement significantly improved disease activity scores and lowered levels of serum C-reactive protein (CRP) [33] . Such findings might indicate species or strain-specific differences between autochthonous and allochthonous Lactobacillus on RA disease activity.
Type 1 diabetes (T1D)
The proportions of Lactobacillus were lower in adults with T1D than healthy, first-degree relatives and unrelated healthy individuals according to untargeted 16S rRNA gene analysis [34 ] (Table 1) . A similar reduction in Lactobacillus was observed in children with T1D [35] ( Table 1) . Interestingly, children exposed to probiotic Lactobacillus early in life were found to have a significantly reduced risk of developing islet autoimmunity [36] . It is not yet understood how Lactobacillus could be regulating islet beta-cell auto-immunity, although it has been suggested that a lack of intestinal lactate-producing bacteria depletes butyrate-producing taxa leading to aberrant immune responses [35] .
Multiple sclerosis (MS)
A cohort study found that the relative abundance of intestinal Lactobacillus was lower in MS patients compared to healthy adults [37] (Table 1 ). Similar depletions in intestinal Lactobacillus were observed in a preclinical, rodent model of MS [38] . Consistent with a benefit of Lactobacillus in this autoimmune disease were the findings from a recent RCT of MS patients, whereby consumption of a multi-species probiotic improved the expanded disability status score, self-reported depression, anxiety and stress, as well as decreased serum CRP [39] . Because circulating levels of AHR ligands are lower in MS patients compared to healthy adults [40] , Lactobacillus might be useful for the maintenance or replenishment of these compounds. To this regard, Lactobacillus-produced indole aldehydes had a potent anti-inflammatory effect on brain glial cells (astrocytes) to limit central nervous system inflammation in a mouse model of human MS [41 ] .
Obesity and type 2 diabetes (T2D)
There are conflicting reports on the association of intestinal Lactobacillus with obesity in humans [42] [43] [44] [45] ( Table 1) . Likewise, initial studies found increased levels of Lactobacillus in patients with T2D [46] , although this trend was eliminated or reversed when controlling for
Intestinal Lactobacillus in health and disease Heeney, Gareau and Marco 143 metformin treatment [47] (Table 1) . Moreover, metaanalysis of RCT studies found that probiotic Lactobacillus improved weight management outcomes in obese adults [48] . Consumption of yogurt and other dairy products fermented by Lactobacillus is also correlated with protection from T2D and obesity (recently reviewed in [2] ).
Because Lactobacillus species appear to be either associated with weight gain or weight loss [49] , the disparate findings among obese individuals might be due to genetic differences among the lactobacilli. Strain and species distinctions could result in variations in carbohydrate metabolism and production of fermentation end-products, such as lactate [50] . The synthesis of bile salt hydrolases is another distinguishing feature of some Lactobacillus species, an activity that can alter the activation of farnesoid x receptor (FXR) signaling and hepatic lipid metabolism [51, 52] .
Cancer
In a systematic review of thirty-one studies, Lactobacillus along with a limited number of butyrogenic genera were consistently diminished in colorectal cancer patients [53] ( Table 1 ). Preventative and therapeutic roles of Lactobacillus in cancer are supported in studies with preclinical, rodent models, including a recently study in which a multi-strain probiotic altered Th-cell polarization away from Th17 cells in a mouse model of hepatocellular carcinoma [54] . However, Lactobacillus might not always be beneficial in certain extra-intestinal sites as shown by the higher levels of Lactobacillus in malignant breast cancer compared to benign-disease tissues [55] . There was also a positive association between the levels of this genus in the oral microbiome and head and neck squamous cell carcinoma [56] (Table 1) .
Cognitive development and behavior
Maternal prenatal stress might influence the infant microbiome, potentially damaging cognitive development. In humans, prenatal cortisol concentrations were inversely correlated with infant levels of intestinal Lactobacillus and Lactococcus, whereas Proteobacteria were enriched [57 ] ( Table 1) . A comparable depletion of Lactobacillus was observed in rodent models of prenatal stress, with the microbiome of the offspring remaining disrupted into adulthood [58] . Prenatal low-dose penicillin [59] or high fat diet [60 ] could similarly induce long-term dysbiosis and behavioral deficits in mice. These deficits could be prevented by concurrent administration of Lactobacilluscontaining probiotics to the dam [59] or by indigenous L. reuteri to offspring [60 ] .
In adult mouse models of microbiota-gut-brain axis deficits, administration of Lactobacillus probiotics was found to beneficially impact both cognition and colonic function, while reversing intestinal dysbiosis [61, 62] . Such results might also be relevant to emotional disorders and this is supported in probiotics studies which have indicated that probiotic Lactobacillus might improve symptoms of human depression [63, 64] . Therefore, beneficially modulating the microbiota using Lactobacillus can impact the microbiota-gut-brain axis and should be more thoroughly studied in human mother-infant cohorts.
Conclusions
Our increased understanding of intestinal Lactobacillus from untargeted microbiome studies supports the premise that general properties conferred by this genus have far-reaching consequences on human health. This possibility could be further investigated via studies designed to determine the proximity of Lactobacillus to the intestinal epithelium or which focus attention on other sites on the body wherein members of this genus can constitute the majority of bacteria present (e.g. vagina). Moreover, strain and/or species-specific differences (e.g. tryptophan and bile metabolism) might be useful to explain variations in the involvement of this genus, either in the prevention or mitigation of disease or, alternatively, as a contributing factor to disease outcomes. Furthermore, the notable variation in intestinal abundance of this genus between healthy and diseased, or health-compromised, individuals indicates that Lactobacillus, or at least certain species or genotypes of Lactobacillus, might be useful gut biomarkers. These considerations can also inform the improved development and use of probiotics in different human populations.
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